Rgenta Therapeutics Funding & Investors
Brookline, MA
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.
rgentatx.comTotal Amount Raised: $116,949,200
Rgenta Therapeutics Funding Rounds
Series A
$8,000,000
Series A Investors
HighLight CapitalThe Leukemia & Lymphoma Society's Therapy Acceleration ProgramSeries A
$52,000,000
Series A Investors
AstraZenecaCICCDelos CapitalKorea Investment PartnersMatrix Partners ChinaVivo CapitalLilly Asia VenturesKaitai CapitalBoehringer Ingelheim Venture FundLegend StarSeries Unknown
$8,914,283
Seed
$18,000,000
Seed Investors
Vivo CapitalLilly Asia VenturesKaitai CapitalSeed
$20,000,000
Seed Investors
Boehringer Ingelheim Venture FundMatrix Partners ChinaKaitai CapitalLegend StarSeries Unknown
$10,034,915
Funding info provided by Diffbot.